Xinde Semiconductor Files for Hong Kong IPO: Accumulated Losses Exceed 1.3B Yuan in 3.5 Years, Two Shareholders Cash Out 17.19M Yuan Before Listing

Deep News
2025/11/06

On October 31, 2025, Xinde Semiconductor, a five-year-old company, submitted its listing application to the Hong Kong Stock Exchange for a main board IPO. Headquartered in Nanjing, Jiangsu, this semiconductor packaging and testing solutions provider has emerged as one of China's few advanced packaging firms with comprehensive capabilities in QFN, BGA, LGA, WLP, and 2.5D/3D technologies.

Behind its rapid revenue growth and cutting-edge technological prowess, however, Xinde Semiconductor faces multiple risks including persistent losses, negative equity, and pre-IPO shareholder cash-outs.

**Revenue Growth vs. Sustained Losses** From 2022 to 2024, Xinde Semiconductor demonstrated strong revenue growth, with sales increasing from 269 million yuan to 827 million yuan at a CAGR exceeding 40%. In the first half of 2025, revenue reached 475 million yuan, up 22% year-on-year.

Yet profitability remained elusive. The company reported losses of 360 million yuan, 359 million yuan, and 377 million yuan in 2022–2024, respectively. Over three and a half years, cumulative losses surpassed 1.3 billion yuan.

Notably, high sales costs—4.84 billion yuan, 7.05 billion yuan, and 9.94 billion yuan from 2022 to 2024—continued to erode margins despite revenue growth. While Xinde attributed losses primarily to equipment depreciation, financing costs, and employee share-based payments, depreciation accounted for less than 26% of sales costs, suggesting deeper profitability challenges.

**Widening Negative Equity** As of June 30, 2025, Xinde held 149 million yuan in cash against 3.579 billion yuan in total assets, while liabilities ballooned to 4.53 billion yuan, leaving a 950 million yuan equity deficit. This shortfall has expanded annually: negative equity stood at -343 million yuan, -750 million yuan, -916 million yuan, and -950 million yuan from 2022 to mid-2025.

Cash flow data revealed 82.96 million yuan from operations in H1 2025, dwarfed by 345 million yuan in investment outflows, underscoring heavy reliance on external funding. Accounts receivable also grew alarmingly, rising from 65.5 million yuan in 2022 to 186 million yuan by mid-2025, with impairment provisions climbing yearly.

**Customer Concentration Risks** Xinde’s top five clients contributed 60.5%, 50.4%, 53.0%, and 55.2% of revenue during the reporting period, with the largest single customer accounting for 24.3%–27.3%. Domestic sales dominated, rising from 93.9% to 97.9% of total revenue, though the company aims to expand into South Korea, Japan, the U.S., and Germany.

**Pre-IPO Shareholder Cash-Outs** Months before filing, multiple shareholders cashed out over 77 million yuan via share transfers. On July 3, 2025, Shenzhen Gongchuang and Ningpu Xin sold stakes totaling 60 million yuan, followed by Sumin Investment and Pioneer Investment’s 17.192 million yuan exit on September 30. Such moves, while common in VC exits, may raise investor concerns.

As of the prospectus date, a shareholder group including Zhang Guodong, Pan Mingdong, Liu Yi, Ningtaixin, and Ningpuxin held 24.95% voting rights. Other backers include Jiangsu state-owned capital, Chenyi Fund, and Xiaomi Yangtze River Industry Fund.

Xinde plans to use IPO proceeds for production base construction, new lines, and equipment procurement to meet market demand. Investors must weigh its technological edge against financial risks, monitoring capacity expansion, margin recovery, and client diversification for sustainable value creation.

*(Note: AI-assisted content. Not investment advice. Market risks apply.)*

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10